UAB Pharmaplius Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data
| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2022 |
|---|
| 2,715,989 |
| 1,357,995 |
| 130,693 |
| 111,089 |
| 55,545 |
| 13.09 |
| 4.09 |
| 393,428 |
| 360,163 |
| 25,185 |
| 726,980 |
| 2023 |
|---|
| 5,843,285 |
| 2,907,107 |
| 639,077 |
| 543,215 |
| 270,256 |
| 14.84 |
| 9.30 |
| 936,643 |
| 256,396 |
| 18,619 |
| 1,172,639 |
| 2024 |
|---|
| 15,376,630 |
| 4,418,572 |
| 2,658,469 |
| 2,259,699 |
| 649,339 |
| 21.68 |
| 14.70 |
| 1,544,342 |
| 1,068,485 |
| 126,244 |
| 2,484,827 |
Register and
explore Okredo data| 2024 |
|---|
| 15,376,630 |
| 4,418,572 |
| 2,658,469 |
| 2,259,699 |
| 649,339 |
| 21.68 |
| 14.70 |
| 1,544,342 |
| 1,068,485 |
| 126,244 |
| 2,484,827 |
Register and
explore Okredo data2024
Turnover (€)
15,376,630 €
163 % *
Sales per employee (€)
4,418,572 €52 % *
Profit before tax (€)
2,658,469 €316 % *
Net Profit (€)
2,259,699 €316 % *
Profit per employee (€)
649,339 €140 % *
Total profitability (%)
21.68 %46.09 % *
Net profitability (%)
14.70 %58.06 % *
Equity (€)
1,544,342 €65 % *
Amounts Payable And Liabilities (€)
1,068,485 €
317 % *
Non-current Assets (€)
126,244 €578 % *
CurrentAssets (€)
2,484,827 €112 % *